𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Quantitative analysis of estrogen receptor-β mRNA and its variants in human breast cancers

✍ Scribed by Kyoko Iwao; Yasuo Miyoshi; Chiyomi Egawa; Noriko Ikeda; Shinzaburo Noguchi


Publisher
John Wiley and Sons
Year
2000
Tongue
French
Weight
74 KB
Volume
88
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


We have carried out a quantitative analysis of ER-alpha and ER-beta mRNA expression in normal (n = 11) and breast cancer (n = 112) tissues using a real-time (Taq-Man) PCR assay. Expression of ER-beta mRNA variants has also been studied by triple-primer PCR assay. ER-alpha mRNA levels in normal breast tissues were significantly (p < 0.01) lower than those in ER-positive breast cancers but not significantly different from those in ER-negative breast cancers. However, ER-beta mRNA levels in normal breast tissues were significantly (p < 0.01) higher than those in ER-positive and ER-negative breast cancers. Proportions of ER-beta1 and ER-beta2 mRNA expression among total ER-beta mRNA expression were significantly higher and those of ER-beta5 and ER-beta5; mRNA were significantly lower in normal breast tissues than in ER-positive and ER-negative breast cancers. ER-beta mRNA levels and proportions of ER-beta mRNA variants did not show any significant correlation with age, tumor size, lymph node status and histological grade. Our results demonstrate that ER-alpha mRNA is up-regulated and ER-beta mRNA is down-regulated during carcinogenesis of breast cancers. Changes in proportions of ER-beta mRNA variants are also implicated in this process.


📜 SIMILAR VOLUMES


Identification of an exon 3 deletion spl
✍ Xiang Zhu; Angela A.I. Daffada; Christina M.W. Chan; Mitchell Dowsett 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 241 KB 👁 2 views

Androgens and androgen receptor (AR) are involved in many regulatory processes in the growth of female breast cells. Mutations in the AR gene and/or alterations of the AR protein sequence may be related to the development and progression of breast cancer. Using reverse transcriptionpolymerase chain

Analysis of the potential contribution o
✍ J.P. Brouillet; M.A. Dujardin; D. Chalbos; J.M. Rey; J. Grenier; P.J. Lamy; T. M 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 84 KB 👁 1 views

Estrogen receptor (ER) content is the most useful parameter for predicting hormone response therapy in breast cancer. Assays available for detecting ER in breast tumor cytosol are ligand-binding assay (LBA), which detects both ER␣ and ER␤, and the enzymatic immunoassay (EIA), in which monoclonal ant

Quantitative analysis of estrogen recept
✍ Kyoko Iwao; Yasuo Miyoshi; Chiyomi Egawa; Noriko Ikeda; Fumine Tsukamoto; Shinza 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

## Background: Estrogen action is mediated not only through a classic estrogen receptor (er) (er-alpha) but also through a second er (er-beta) that has a structure and function similar to er-alpha. a correlation between er-beta mrna expression with er and progesterone receptor (pr) protein levels a